Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?

Jong Eun Yeon

doi:10.3350/cmh.2018.1009

Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?

Jong Eun Yeon

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	294-296
Number of pages	3
Journal	Clinical and Molecular Hepatology
Volume	24
Issue number	3
DOIs	https://doi.org/10.3350/cmh.2018.1009
Publication status	Published - 2018 Sept 1

Keywords

Chronic hepatitis C
Genotype 2
Ribavirin
Sofosbuvir

ASJC Scopus subject areas

Hepatology
Molecular Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3350/cmh.2018.1009

Cite this

@article{8801382a09864a168163942534ff756b,

title = "Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?",

keywords = "Chronic hepatitis C, Genotype 2, Ribavirin, Sofosbuvir",

author = "Yeon, {Jong Eun}",

year = "2018",

month = sep,

day = "1",

doi = "10.3350/cmh.2018.1009",

language = "English",

volume = "24",

pages = "294--296",

journal = "Clinical and Molecular Hepatology",

issn = "2287-2728",